“We need to convince senior managers in local countries to invest appropriately in market access.”
PAREXEL conducted in-depth interviews with industry leaders to glean their expert opinion on market access and product commercialization and to identify best practice. Interviewing a range of industry influencers has also identified emerging practices and common challenges.
Some of the findings include:
• 86% of industry leaders agreed market access planning is key
• Most felt market access should be invested in throughout development
• 3 in 4 agreed that clinical, regulatory and commercial teams work well together
• The biggest challenges affecting market access are: lack of internal alignment and lack of internal understanding